Skip to content

Clinical trials

Neurocognitive Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: Spain Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20172
20181
20211
20222
20235
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Instituto de Mayores y Servicios Sociales (IMSERSO)2
Avraham Pharmaceuticals Ltd1
Badalona Serveis Assistencials1
Eli Lilly and Company1
Genentech, Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
Novartis Pharmaceuticals1
Stephanie Grasso1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders15
Dementia11
Alzheimer Disease9
Cognitive Dysfunction9
Brain Diseases8
Neurodegenerative Diseases8
Central Nervous System Diseases7
Nervous System Diseases7
Mental Disorders6
Tauopathies6

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.